Clinical Trial Update: Effects of Ramelteon (8mg) Alone and in Combination With Multi-Component Behavioral Therapy on Sleep and Circadian Phase in Patients With Chronic Insomnia [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial update evaluates ramelteon 8 mg, alone and in combination with multi-component behavioral therapy, for improving sleep and circadian…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insomnia

Drugs mentioned

• Ramelteon (ramelteon)

Snippet

Sponsor: University of Arizona | Conditions: Insomnia | Phase 4 | Status: UNKNOWN